boswellic acid has been researched along with 2019 Novel Coronavirus Disease in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abd-Ellatief, RB; Gomaa, AA; Gomaa, MA; Mohamed, HS | 1 |
| Ammon, HPT; Caliebe, RH; Scior, T | 1 |
1 review(s) available for boswellic acid and 2019 Novel Coronavirus Disease
| Article | Year |
|---|---|
Boswellic acids/Boswellia serrata extract as a potential COVID-19 therapeutic agent in the elderly.
Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Boswellia; COVID-19; COVID-19 Drug Treatment; Humans; Plant Extracts; Triterpenes | 2021 |
1 other study(ies) available for boswellic acid and 2019 Novel Coronavirus Disease
| Article | Year |
|---|---|
Binding of boswellic acids to functional proteins of the SARS-CoV-2 virus: Bioinformatic studies.
Topics: Adenosine Monophosphate; Alanine; Anti-Inflammatory Agents, Non-Steroidal; Antiviral Agents; Binding Sites; Boswellia; Computational Biology; COVID-19; COVID-19 Drug Treatment; Humans; Molecular Docking Simulation; Nucleoproteins; Polyproteins; Prodrugs; Protein Binding; SARS-CoV-2; Spike Glycoprotein, Coronavirus; Structure-Activity Relationship; Triterpenes; Viral Proteins | 2021 |